agreed with your assessment of point three but I would say that literally the amount of scientists working on this would be unprecedented. if they develop vaccine governments will engage their powers to ensure it is manufactured as quickly as possible.
We do have vaccines for flus etc it’s just that the virus mutates each year.
I still question is this now a MM company or are they changing direction?
what of LSE and Malta etc etc.
Ann: Phase II Clinical Trial on Patients Diagnosed with COVID-19, page-15
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.065(39.4%) |
Mkt cap ! $11.13M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 23.0¢ | 17.5¢ | $97.37K | 451.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 6921 | 5 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |